Literature DB >> 25903070

Activation of mineralocorticoid receptor in salt-sensitive hypertension.

Nobuhiro Ayuzawa1, Toshiro Fujita.   

Abstract

The impaired capacity of the kidney to excrete sodium plays an essential role in the development of hypertension. Adrenal corticosteroids control renal handling of sodium by regulating tubular sodium reabsorption in the distal nephron where both mineralocorticoid receptors (MR) and glucocorticoid receptors are expressed. In addition, cell type- and segment-specific expression of 11β-HSD2 and sodium transporters such as Na-Cl cotransporter (NCC), epithelial sodium channel (ENaC), and pendrin/Na(+)-driven Cl(-)/HCO3 (-) exchanger (NDCBE) builds a distinctive model of sodium transport in the aldosterone-sensitive distal nephron. Aberrant MR activation in the distal nephron triggers salt-sensitive hypertension and hypokalemia through inappropriate sodium reabsorption and potassium secretion. However, MR activity is not necessarily modulated by the ligand alone. Recently, several lines of evidence revealed alternative mechanisms that regulate the activity of MR in a ligand-independent manner or through ligand binding modulation. This review summarizes the disorders related to MR activation in individual tubular cells and highlights the renal mechanism of salt-sensitive hypertension and new approaches for the prevention and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25903070     DOI: 10.1007/s11906-015-0552-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  84 in total

Review 1.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

3.  Renal intercalated cells are rather energized by a proton than a sodium pump.

Authors:  Régine Chambrey; Ingo Kurth; Janos Peti-Peterdi; Pascal Houillier; Jeffrey M Purkerson; Françoise Leviel; Moritz Hentschke; Anselm A Zdebik; George J Schwartz; Christian A Hübner; Dominique Eladari
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

4.  Chloride-dominant salt sensitivity in the stroke-prone spontaneously hypertensive rat.

Authors:  Olga Schmidlin; Masae Tanaka; Andrew W Bollen; Sai-Li Yi; R Curtis Morris
Journal:  Hypertension       Date:  2005-04-18       Impact factor: 10.190

5.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

6.  Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing.

Authors:  A N Smith; J Skaug; K A Choate; A Nayir; A Bakkaloglu; S Ozen; S A Hulton; S A Sanjad; E A Al-Sabban; R P Lifton; S W Scherer; F E Karet
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Genetically determined chloride-sensitive hypertension and stroke.

Authors:  M Tanaka; O Schmidlin; S L Yi; A W Bollen; R C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT.

Authors:  V Câmpean; J Kricke; D Ellison; F C Luft; S Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2001-12

9.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

Authors:  Heon Yung Gee; Pawaree Saisawat; Shazia Ashraf; Toby W Hurd; Virginia Vega-Warner; Humphrey Fang; Bodo B Beck; Olivier Gribouval; Weibin Zhou; Katrina A Diaz; Sivakumar Natarajan; Roger C Wiggins; Svjetlana Lovric; Gil Chernin; Dominik S Schoeb; Bugsu Ovunc; Yaacov Frishberg; Neveen A Soliman; Hanan M Fathy; Heike Goebel; Julia Hoefele; Lutz T Weber; Jeffrey W Innis; Christian Faul; Zhe Han; Joseph Washburn; Corinne Antignac; Shawn Levy; Edgar A Otto; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

10.  Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Authors:  James M Luther; Pengcheng Luo; Zuofei Wang; Samuel E Cohen; Hyung-Suk Kim; Agnes B Fogo; Nancy J Brown
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

View more
  4 in total

1.  Aldosterone Regulates Pendrin and Epithelial Sodium Channel Activity through Intercalated Cell Mineralocorticoid Receptor-Dependent and -Independent Mechanisms over a Wide Range in Serum Potassium.

Authors:  Truyen D Pham; Jill W Verlander; Yanhua Wang; Cesar A Romero; Qiang Yue; Chao Chen; Monika Thumova; Douglas C Eaton; Yoskaly Lazo-Fernandez; Susan M Wall
Journal:  J Am Soc Nephrol       Date:  2020-02-13       Impact factor: 14.978

Review 2.  Renal intercalated cells and blood pressure regulation.

Authors:  Susan M Wall
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

3.  Salt-dependent Blood Pressure in Human Aldosterone Synthase-Transgenic Mice.

Authors:  Huiying Gu; Zhizhong Ma; Jian Wang; Timothy Zhu; Nicole Du; Adam Shatara; Xin Yi; Mark C Kowala; Yansheng Du
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

4.  Characteristics and variation of fecal bacterial communities and functions in isolated systolic and diastolic hypertensive patients.

Authors:  Pan Wang; Ying Dong; Kun Zuo; Chunming Han; Jie Jiao; Xinchun Yang; Jing Li
Journal:  BMC Microbiol       Date:  2021-04-26       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.